Related Experiment Videos
Immunogenicity of membrane-bound gangliosides in viable whole-cell vaccines
1Laboratory of Glycolipid Immunotherapy, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, California 90404, USA.
Cancer Investigation
|January 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Immunology of gangliosides.
Indian journal of experimental biology·2001
Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma.
CA: a cancer journal for clinicians·2001
Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I-III melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2000
Unfractionated Heparin and Low-Molecular-Weight Heparin in Sepsis: Anti-Inflammatory and Anticoagulant Effects Versus No Anticoagulation-A Propensity Score-Matched Analysis.
Journal of clinical laboratory analysis·2026
The ubiquitin system in normal and infected germinal center B cells.
FEBS letters·2026
Gut Microbiota Mediates the Relationship Between Immune Cells and Familial Hypercholesterolemia: A Mendelian Randomization Study.
Endocrine, metabolic & immune disorders drug targets·2026
Tumor-responsive nanoparticles precisely overcome hypoxia-mediated STING dysfunction to unleash potent antitumor immunity.
Acta pharmaceutica Sinica. B·2026
Self-assembled supramolecular nanoparticles of α-mangostin for targeted STING activation and enhanced tumor immunotherapy.
Acta pharmaceutica Sinica. B·2026